Betty Aburime
Primary Care · Irving, TXNPI 1326467705
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AstraZeneca at 27.7% of the total. Among primary care clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $27.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$811
- CSL Behring$357
- Sanofi$267
- GSK$191
- Takeda Pharmaceuticals U.S.A., Inc.$166
- Teva Pharmaceuticals USA, Inc.$129
- plus $1K from 24 others
What the payments were for
- Consulting fees$1023%
- Food & beverage$2,82597%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $811 |
| CSL Behring | 12 | $357 |
| Sanofi | 3 | $267 |
| GSK | 3 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $166 |
| Teva Pharmaceuticals USA, Inc. | 3 | $129 |
| ADMA Biomanufacturing LLC | 6 | $124 |
| Novartis | 5 | $92 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| AbbVie | 5 | $74 |
| Biocryst US Sales Co., LLC | 4 | $72 |
| Pharming Healthcare, Inc. | 3 | $68 |
| Abbott | 3 | $66 |
| Optinose US, Inc. | 3 | $54 |
| Pfizer | 2 | $49 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| Boehringer Ingelheim | 2 | $34 |
| Johnson & Johnson | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Alk-abello, Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Tersera Therapeutics LLC | 1 | $18 |
| Bayer | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $16 |
| Exact Sciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,927 in reported general payments places this provider in the 90th percentile of 563 primary care providers in Texas.
Other primary care in Irving
- Mary GibbensHouston$42K
- Phillip GulleySan Antonio$23K
- Herbert BautistaDallas$14K
- Brandi JoynerLongview$12K
- Steven ParisAustin$10K
- Hope OdomCollege Station$10K
- Arlena GraysTomball$9K
- Charlotte BallardSan Antonio$9K
- Hannah LancasterMcKinney$9K
- Jacqueline MilesGrand Prairie$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.